Risk Assessment & Early Detection
Risk Assessment & Early Detection
Inherited susceptibility and screening strategies, distinguishing established from emerging tests.
Read clinical details ↗
Cancer Genetics | From Diagnosis to Care Decisions
Specialist Services in
Specialist Services in
Cancer Genetics
From molecular biomarker identification and tumor profiling to choosing the right test and interpreting results—supporting informed clinical decisions.
Clinical applications
Start with your clinical question
Four clinical pathways to guide test selection. Each has a dedicated, in-depth reference page.
Molecular Characterization
Molecular Characterization
Characterize tumor alterations using DNA/RNA and targeted complementary assays.
Read clinical details ↗Precision Treatment Guidance
Precision Treatment Guidance
Review molecular evidence supporting targeted therapy and immunotherapy by cancer type.
Read clinical details ↗Monitoring, MRD & Relapse
Monitoring, MRD & Relapse
Evaluate residual disease, response, and resistance in defined indications.
Read clinical details ↗Tests & services
Find the appropriate test
Search by specimen, clinical indication, or analysis. Availability of any service requires confirmation of the laboratory’s validated scope.
Risk Assessment
Hereditary cancer genetic assessment
Hereditary Cancer Panel
Identify germline variants associated with inherited cancer susceptibility
Molecular Profiling
Comprehensive genomic tumor profiling
Comprehensive Tumor Profiling
Identify cancer-associated genomic alterations and their clinical relevance
Treatment Guidance
Blood ctDNA profiling
Liquid Biopsy ctDNA
Molecular assessment of circulating tumor-derived DNA
Disease Monitoring
Molecular MRD monitoring
MRD Monitoring
Detect molecular evidence of residual disease in validated settings
Diagnosis & Profiling
Hematologic malignancy profiling
Hematologic NGS Panel
DNA/RNA profiling in hematologic malignancies
Early Detection
Multi-cancer early detection
Early Detection Analysis
Evaluate cancer-associated molecular signals within defined and validated settings
Targeted Therapy
Targeted lung cancer panel
Lung Cancer Targeted Panel
Identify molecular biomarkers relevant to NSCLC
Multi-Omics
Comprehensive RNA analysis
Transcriptomics / RNA-Seq
Analyze gene expression and clinically relevant RNA alterations
No tests match your search. Try another term or contact the specialist team.
Cancer types
Explore by cancer type
Browse the relevant tests, biomarkers, and clinical contexts for each cancer.
NSCLC
Lung cancer
Breast cancer
Breast cancer
Colorectal cancer
Colorectal cancer
Ovarian cancer
Ovarian cancer
Melanoma
Melanoma
Prostate cancer
Prostate cancer
Leukemia
Leukemia
Lymphoma
Lymphoma
Lynch syndrome
Lynch syndrome
HBOC
Hereditary breast and ovarian cancer
Multiple myeloma
Multiple myeloma
Gastric cancer
Gastric cancer
Biomarkers
Molecular information with clinical context
Explore genes and biomarkers by clinical significance, associated tumors, and testing methodology.
⌬
EGFR / ALK / ROS1
Mutations and rearrangements guiding therapy in selected lung cancers.
Clinical applications⌬
BRCA1/2 & HRD
DNA-repair genes and signatures with distinct germline and tumor applications.
Clinical applications⌬
MSI / MMR
Mismatch-repair deficiency markers used for diagnosis and context-dependent treatment decisions.
Clinical applications⌬
TMB
Tumor mutational burden; interpretation depends on the cancer type and assay.
Clinical applications⌬
PD-L1
Protein biomarker with indication-specific assay and scoring thresholds.
Clinical applications⌬
KRAS / BRAF / PIK3CA
Key signaling-pathway alterations associated with selected targeted therapies.
Clinical applicationsWorkflow
From clinical request to interpretable report
A clear workflow helps clinicians and patients understand the next step and when specialist input is needed.
1
Define the clinical question
Identify the cancer type, clinical history, and testing objective.
2
Submit specimen
Prepare and submit the specimen according to collection, quality, and transport requirements.
3
Quality control and analysis
Molecular processing, bioinformatics, and review of results.
4
Reporting and interpretation
Explain the findings and their limitations in the clinical context.
Knowledge center
Resources for informed decisions
From patient-oriented explanations to technical resources for oncologists and laboratory professionals.
📖
Understanding test results
Understand positive, negative, and VUS findings, test limitations, and when genetic counseling is warranted.
Further details
Interpret positive, negative, and uncertain findings in the context of personal and family history and assay limitations. This information alone must not determine treatment.
🧪
Specimen collection guide
Compare blood, FFPE tissue, and other specimens, including acceptance criteria.
Further details
Specimen requirements depend on the assay. Tissue condition, tumor content, DNA/RNA quality, and transport time must follow assay-specific instructions.
📊
Scientific evidence and sample reports
Scientific references, validation methods, case studies, and standard report structure.
Further details
Relevant studies, assay validation data, and reporting templates can be discussed with clinical collaborators. Contact our team for details.
Specialist support
Cannot find the right test?
Submit a request using the form or contact our specialist support team.
DIRECT CONTACT
Direct contact with our specialists
Discuss specimen requirements, panel differences, analysis feasibility, and referral workflows.
☎ +983133932341Chat on WhatsApp ↗For case-specific questions, initially describe only the clinical question and cancer type. Share medical records exclusively through an approved secure channel.
Verify your mobile number
Request submitted
Your mobile number was verified and your request has been saved. Reference: